Percutaneous Nephrolithotomy Market Report 2026

Percutaneous Nephrolithotomy Market Overview

• Percutaneous Nephrolithotomy market size has reached to $19.39 billion in 2025 • Expected to grow to $28.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Impact Of Rising Renal Disease Prevalence On The Growth Of The Percutaneous Nephrolithotomy Market • Market Trend: Advancements In Robot-Assisted Surgical Platforms Propel The Percutaneous Nephrolithotomy Market • North America was the largest region in 2025.

What Is Covered Under Percutaneous Nephrolithotomy Market?

Percutaneous nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove kidney stones (renal calculi) from the urinary tract. This procedure involves making a small incision in the skin and creating a direct channel to the kidney through which instruments are inserted to break up and extract the stones. PCNL is employed when other less invasive methods, such as shock wave lithotripsy or ureteroscopy, are ineffective or unsuitable. The main types of percutaneous nephrolithotomy are magnesium ammonium phosphate stone type, calcareous type, and uric acid calculi type. Magnesium Ammonium Phosphate (MAP) stones refer to a specific type of kidney stone composed of magnesium, ammonium, and phosphate ions. The different components, including accessories, devices, and services, are utilized by ambulatory surgical centers, clinics, and hospital end users.

What Is The Percutaneous Nephrolithotomy Market Growth Forecast?

The percutaneous nephrolithotomy market size is expected to see strong growth in the next few years. It will grow to $28.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to advancements in flexible and miniaturized nephrolithotomy devices, increasing adoption of minimally invasive urology procedures, expansion of ambulatory surgical centers and clinics, rising patient awareness regarding treatment options, integration of advanced imaging and monitoring systems in procedures. Major trends in the forecast period include increasing use of ai for preoperative planning and stone removal prediction, rising integration of cloud and big data for patient and procedure management, growing use of iot-enabled devices for real-time monitoring during pcnl procedures, increasing implementation of smart manufacturing for pcnl devices and accessories, rising adoption of precision medicine approaches for personalized stone management.

Global Percutaneous Nephrolithotomy Market Segmentation

1) By Type: Magnesium Ammonium Phosphate Stone Type, Calcareous Type, Uric Acid Calculi Type 2) By Component: Accessories, Devices, Services 3) By End-User: Ambulatory Surgical Centers, Clinics, Hospitals Subsegments: 1) By Magnesium Ammonium Phosphate Stone Type: Struvite Stones, Triple Phosphate Stones 2) By Calcareous Type: Calcium Oxalate Stones, Calcium Phosphate Stones 3) By Uric Acid Calculi Type: Primary Uric Acid Stones, Secondary Uric Acid Stones

What Are The Drivers Of The Percutaneous Nephrolithotomy Market?

The increasing prevalence of renal diseases is expected to propel the growth of the percutaneous nephrolithotomy market going forward. Renal diseases refer to a range of conditions that affect the kidneys, impairing their ability to function properly. The prevalence of renal diseases is due to rising rates of diabetes and hypertension, an aging population, poor lifestyle choices, genetic predisposition, chronic conditions, and improved awareness and diagnosis. Percutaneous nephrolithotomy helps manage renal diseases by providing a minimally invasive surgical procedure to remove large or complex kidney stones, alleviate pain, prevent urinary tract infections, and improve kidney function. For instance, in May 2024, according to Kidney Care UK, a UK-based non-profit charity, more than 20 people in the UK develop kidney failure each day. Therefore, the increasing prevalence of renal diseases is driving the percutaneous nephrolithotomy industry. The increasing adoption of minimally invasive surgeries is expected to propel the growth of the percutaneous nephrolithotomy market. Invasive surgeries are medical procedures that involve entering the body, usually by making incisions, to treat or diagnose medical conditions. The increasing adoption of minimally invasive surgeries (MIS) is driven by key advantages such as reduced recovery time and hospital stays, lower risk of complications, less pain and scarring, and enhanced precision through advanced technology. The minimally invasive surgeries significantly benefit the percutaneous nephrolithotomy (PCNL) by this less invasive approach to treating kidney stones. For instance, in April 2025, according to reports published by Intuitive Surgical Inc., a US-based manufacturer of robotic products, hospitals that implemented RAS saw MIS rates increase from 60.5% to 65.8%, a significantly greater rise than hospitals that did not introduce RAS (56.1% to 57.0%). Therefore, the increasing adoption of minimally invasive surgeries is driving the growth of the percutaneous nephrolithotomy industry.

Key Players In The Global Percutaneous Nephrolithotomy Market

Major companies operating in the percutaneous nephrolithotomy market are Boston Scientific Corporation, Olympus Corporation, Cook Medical, Karl Storz SE And Co. KG, Merit Medical Systems, Richard Wolf GmbH, Dornier MedTech, EDAP TMS, ELMED Lithotripsy Systems, Advin Urology, Siemens Healthineers AG, Stryker Corporation, Lumenis Ltd, HealthTronics Inc, Rocamed SAM, Quanta System S.p.A, GEMMS Co Ltd, Pusen Medical Technology Co Ltd, Storz Medical AG, Jena Med Tech, Shenzhen Hyde Medical Equipment, Allium Medical Solutions Ltd, Medtronic plc, Nanjing Minimally Invasive Medical Technology Co Ltd.

Global Percutaneous Nephrolithotomy Market Trends and Insights

Major companies operating in the percutaneous nephrolithotomy market are focused on adopting innovative solutions, such as robot-assisted surgical platforms, to enhance surgical precision and patient outcomes. A robot-assisted surgical platform is an advanced medical system that uses robotic technology to assist surgeons in performing complex procedures with greater precision, control, and flexibility. For instance, in February 2023, Ethicon Inc., a US-based MedTech company, reported the successful robotic-assisted removal of kidney stones in the first patient using the MONARCH Platform for urology. It allows urologists to navigate through the kidney using robotic assistance designed for access, clearance, and control using a handheld controller. The platform provides a single platform that supports ureteroscopic and percutaneous nephrolithotomy (PCNL) procedures, offering improved navigation, access, clearance, and control compared to traditional methods.

Regional Outlook

North America was the largest region in the percutaneous nephrolithotomy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Percutaneous Nephrolithotomy Market?

The percutaneous nephrolithotomy market consists of revenues earned by entities by providing services such as preoperative consultation and assessment, imaging services, anesthesia services, and postoperative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous nephrolithotomy market also includes sales of nephroscopes, lithotripters, and guidewires. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Percutaneous Nephrolithotomy Market Report 2026?

The percutaneous nephrolithotomy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous nephrolithotomy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.